Frequently Asked Questions
Common Questions About Using ICD-10 Code E85.82 for Wild-type transthyretin-related (ATTR) amyloidosis
What are the common symptoms of Wild-type transthyretin-related (ATTR) amyloidosis?
Common symptoms include fatigue, shortness of breath, peripheral neuropathy, and gastrointestinal disturbances. Patients may also experience heart failure symptoms due to amyloid deposits affecting cardiac function.
How is Wild-type transthyretin-related (ATTR) amyloidosis diagnosed?
Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy to confirm amyloid deposits. Blood tests may also be conducted to assess organ function.
What treatment options are available for Wild-type transthyretin-related (ATTR) amyloidosis?
Treatment focuses on managing symptoms and may include medications for heart failure, pain management for neuropathy, and supportive care. In some cases, advanced therapies may be considered.
Is Wild-type transthyretin-related (ATTR) amyloidosis hereditary?
Wild-type transthyretin-related (ATTR) amyloidosis is not hereditary; it typically occurs sporadically, primarily affecting older adults. However, hereditary forms exist due to genetic mutations.
